HistoSonics raises $250M for global expansion
Minneapolis‑based medtech HistoSonics raised $250 million to scale its noninvasive ultrasound tumor‑treatment platform globally, according to the Twin Cities Business Journal on Oct. 16, 2025. Investors include Bezos Expeditions and Thiel Capital, and the company says the financing will accelerate commercialization and expansion of its histotripsy technology, with implications for its Twin Cities operations.
📌 Key Facts
- $250 million funding round announced Oct. 16, 2025
- Investors include Bezos Expeditions and Thiel Capital
- Funds will accelerate global commercialization of HistoSonics’ ultrasound tumor‑treatment technology